Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,961
-$19,770 QoQ
Shares Held
3,174
-34.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 132 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. KROS ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in KROS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,961 | 3,174 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $53,731 | 4,867 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $115,603 | 5,678 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $91,201 | 5,765 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $134,941 | 10,108 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $18,402 | 1,806 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $178,182 | 11,256 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $274,437 | 4,726 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $207,157 | 4,533 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $166,095 | 2,509 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $354,936 | 8,927 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $163,319 | 5,123 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $206,322 | 5,135 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $102,136 | 2,392 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $142,378 | 2,965 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $18,019 | 479 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,834 | 356 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $67,159 | 1,235 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $215,081 | 3,676 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $56,688 | 1,433 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $49,647 | 1,169 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $78,968 | 1,283 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $31,460 | 446 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,895 | 101 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,751 | 100 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||